127 related articles for article (PubMed ID: 34825776)
1. TGFβ-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor prognosis in liver cancer.
Bévant K; Desoteux M; Angenard G; Pineau R; Caruso S; Louis C; Papoutsoglou P; Sulpice L; Gilot D; Zucman-Rossi J; Coulouarn C
Hepatol Commun; 2022 May; 6(5):1157-1171. PubMed ID: 34825776
[TBL] [Abstract][Full Text] [Related]
2. FOXS1 is increased in liver fibrosis and regulates TGFβ responsiveness and proliferation pathways in human hepatic stellate cells.
Bates EA; Kipp ZA; Lee WH; Martinez GJ; Weaver L; Becker KN; Pauss SN; Creeden JF; Anspach GB; Helsley RN; Xu M; Bruno MEC; Starr ME; Hinds TD
J Biol Chem; 2024 Mar; 300(3):105691. PubMed ID: 38280429
[TBL] [Abstract][Full Text] [Related]
3. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
[TBL] [Abstract][Full Text] [Related]
4. DNA Methylation of TGFβ Target Genes: Epigenetic Control of TGFβ Functional Duality in Liver Cancer.
Bévant K; Desoteux M; Abdel Wahab AHA; Abdel Wahab SA; Metwally AM; Coulouarn C
Cells; 2021 Aug; 10(9):. PubMed ID: 34571856
[TBL] [Abstract][Full Text] [Related]
5. FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and EMT in gastric cancer.
Wang S; Ran L; Zhang W; Leng X; Wang K; Liu G; Song J; Wang Y; Zhang X; Wang Y; Zhang L; Ma Y; Liu K; Li H; Zhang W; Qin G; Song F
Sci Rep; 2019 Mar; 9(1):5281. PubMed ID: 30918291
[TBL] [Abstract][Full Text] [Related]
6. Forkhead Box S1 Inhibits the Progression of Hepatocellular Carcinoma.
Lei D; Hu G; Chen Y; Hao T; Gao Y; Luo F
Onco Targets Ther; 2020; 13():11839-11848. PubMed ID: 33235470
[TBL] [Abstract][Full Text] [Related]
7. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
[TBL] [Abstract][Full Text] [Related]
9. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
10. Fatty Acids and a High-Fat Diet Induce Epithelial-Mesenchymal Transition by Activating TGFβ and β-Catenin in Liver Cells.
Kwapisz O; Górka J; Korlatowicz A; Kotlinowski J; Waligórska A; Marona P; Pydyn N; Dobrucki JW; Jura J; Miekus K
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525359
[TBL] [Abstract][Full Text] [Related]
11. STMN2 mediates nuclear translocation of Smad2/3 and enhances TGFβ signaling by destabilizing microtubules to promote epithelial-mesenchymal transition in hepatocellular carcinoma.
Zhong FJ; Sun B; Cao MM; Xu C; Li YM; Yang LY
Cancer Lett; 2021 May; 506():128-141. PubMed ID: 33705863
[TBL] [Abstract][Full Text] [Related]
12. Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.
Dang H; Ding W; Emerson D; Rountree CB
BMC Cancer; 2011 Sep; 11():396. PubMed ID: 21929801
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP
Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction induces EMT through the TGF-β/Smad/Snail signaling pathway in Hep3B hepatocellular carcinoma cells.
Yi EY; Park SY; Jung SY; Jang WJ; Kim YJ
Int J Oncol; 2015 Nov; 47(5):1845-53. PubMed ID: 26397987
[TBL] [Abstract][Full Text] [Related]
16. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
Modi SJ; Kulkarni VM
Eur J Med Chem; 2020 Dec; 207():112851. PubMed ID: 33002846
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint molecules are regulated by transforming growth factor (TGF)-
Shrestha R; Bridle KR; Crawford DHG; Jayachandran A
Int J Med Sci; 2021; 18(12):2466-2479. PubMed ID: 34104078
[TBL] [Abstract][Full Text] [Related]
18. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP
Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767
[TBL] [Abstract][Full Text] [Related]
20. miR-639 regulates transforming growth factor beta-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting FOXC1.
Lin Z; Sun L; Chen W; Liu B; Wang Y; Fan S; Li Y; Li J
Cancer Sci; 2014 Oct; 105(10):1288-98. PubMed ID: 25130698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
